Market-View-Feature-Image

View on market: Volatility Prevails, Market is searching for better value

US stocks rose on Monday ahead of central bank decisions, crucial economic data, and earnings reports from four major tech giants with a combined valuation of nearly $10 trillion. Large tech stocks rebounded, while small caps, which had surged up to 10% in July, experienced a decline season. Federal Reserve officials are expected to signal a potential rate cut in the coming months. The Indian benchmark stock indices erased most gains to end a volatile session with marginal gains on Monday as Bharti Airtel Ltd. and HDFC Bank Ltd. dragged. Overseas investors turned net sellers on Monday after a day of buying on Friday last week. Foreign portfolio investors offloaded shares worth Rs 2,474.5 crore.

Economic Calendar:

  • INR :RBI monetary and credit information announcement on 31 July
  • USD : Nonfarm employment change announcement on 31 July
  • USD: FOMC meeting outcome

IPO Watch:

Company Open Close Price View
Akums Drugs & Pharma 30th July 1st Aug 646-679 Risky
Ola Electric 2nd Aug 6th Aug 72-76 Under review
Ceigall Inida 1st Aug 5th Aug 380-401 Under review

Brokerage Radar:

Jefferies on NTPC:

Maintains Buy; hikes target price to Rs 485 from Rs 445.Earnings visibility improves with thermal; 9.6 GW is under construction and 15.2 GW to be awarded. Regulated ROE in place at 15.5% for FY25E-29E; re-rating to continue with execution ramp up.

Jefferies on Finolex Industries:

Maintain Buy; Hike Target Price to Rs 380 from Rs 320.Finolex targets to raise its margin- accretive Plumbing mix to 50% over medium-term vs ~36%.Est +13% Pipes volume CAGR in FY24-26.

Goldman Sachs on Colgate:

Maintains Sell; hikes target price to Rs 2,750 from Rs 2,150.Toothpaste volume growth at high single digits, tooth brush also sees a turnaround. Current competitive environment in oral care allowing for price driven margins increases.

International Markets:

U.S & Europe:

Particulars 29th July Chg. Chg.(%)
Nasdaq 17370.20 12.32 0.07
Dow 40539.93 -49.41 -0.12
FTSE 8292.35 6.64 0.08
CAC 7443.84 -73.84 -0.99
DAX 18320.67 -96.88 -0.53
Dow Fut.* 40680 -91 -0.22

*As per30th July.

Asian markets:

Particulars 30th July Chg. Chg.(%)
GIFT Nifty 24895.50 -65.10 -0.26
Nikkei 38101.24 -367.39 -0.96
Straits Times 3443.41 -0.77 -0.02
Hang Seng 17006.52 -231.82 -1.34
Shanghai 2867.56 -24.50 0.85

Stocks strong on Chart:

Index F&O Cash
LT AARTI IND BEML
RELIANCE ABFRL KAYENS TECH
MARUTI BEL AIA ENG
ULTRATECH CHAMBAL LUMAX
SUN PHA DABUR CORBORANDUM
LUPIN TATA CHEM BLUE STAR

Commodities & Currency:

Particulars Current Price Chg.(%)
USD/INR 83.73 -0.02
Brent 78.64 -0.52
Gold 68124 -0.08
Silver 81200 -0.11

FIIs & DIIs:

Particulars 29 July 26 July
FIIs                          -2474.54 2546.38
DIIs 5665.54 2774.31

News Update:

Company

Tata Steel The company acquired 557 crore shares, aggregating to Rs 7,324.4 crore in T Steel Holdings
RVNL Emerged as the lowest bidder for an order worth Rs 739 crore from the Himachal Pradesh State Electricity Board. The order is to be executed within 24 months.
RITES In collaboration with NHAI for comprehensive consultancy services
Dr Reddy’s Received a positive CHMP opinion from the European Medicines Agency for the proposed Rituximab biosimilar.
CESC The company acquired 63.9% equity shares of the step-down subsidiary, Purvah Green Power for a consideration of Rs 205 crore.
Source: Moneycontrol, Bloomberg Quint, Investing 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

  1. Reports
  2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

  1. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.